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ppendix 1
reoperative and Operative Variables
he following variables were initially screened for a possible
ssociation with postoperative morbidity and mortality: age, sex,
ody mass index (BMI; in kilograms per square meter), FEV1,
LCO, ppoFEV1, ppoDLCO, cardiac comorbidity, type of disease
benign vs malignant), type of operation (lobectomy vs pneumo-
ectomy), and neodjuvant chemotherapy.
Pulmonary function tests were performed according to the
merican Thoracic Society criteria. Results of spirometry were
ollected after bronchodilator administration. DLCO measurement
as performed by using the single-breath method.
FEV1, ppoFEV1, DLCO, and ppoDLCO values were expressed as
ercentages of predicted value for age, sex, and height. ppoFEV1
nd ppoDLCO values were calculated by estimating the amount of
unctioning parenchyma removed during operation by means of
ronchoscopy, computed tomography, and quantitative lung per-
usion.
For the purpose of the present study and in accordance with
revious investigations,4,5 a concomitant cardiac disease was de-
ned as follows: previous cardiac surgery, previous myocardial
nfarction, history of coronary artery disease, and current treatment
or arrhythmia, cardiac failure, or hypertension. We chose to use t
The Journal of Thorachis definition of cardiac comorbidity for the sake of comparison
ith previous studies and for numeric reasons. In fact, breaking
own the variable in the single cardiac diseases would have
esulted in too many cofactors with limited representation. Al-
hough not weighed, all cardiac conditions included in the variable
re widely recognized cardiac risk factors for noncardiac surgery.
utcome Variables
For the purpose of this study, according to previous studies5,8,9
nd to the European Association for Cardiothoracic Surgery/
uropean Society of Thoracic Surgeons thoracic surgery data-
ase,7 the following complications were included: respiratory fail-
re requiring mechanical ventilation for more than 48 hours,
neumonia (chest radiographic infiltrates, increased white blood
ell count, and fever), atelectasis requiring bronchoscopy, adult
espiratory distress syndrome, pulmonary edema, pulmonary em-
olism, myocardial infarction (suggestive electrocardiographic
ndings and increased myocardial enzymes), hemodynamically
nstable arrhythmia requiring medical treatment, cardiac failure
suggestive chest radiographs, physical examination, and symp-
oms), acute renal failure (change in serum creatinine level 2
g/dL compared with preoperative values), and stroke. For nu-
eric reason, we did not separate cardiac and pulmonary compli-
ations. We also did not weigh complications in keeping with most
f the work done on morbidity; however, we included only those
omplications that increased the complexity of postoperative man-
gement, requiring new treatments or a change of treatment, there-
ore adding up to hospital costs and stay.
iscussion
r Mark S. Allen (Rochester, Minn). Dr Yang, Dr Sonett, mem-
ers, and guests. I have no conflicts to disclose other than that I am
member of the Society of Thoracic Surgeons Database Commit-
ee, and therefore my encouragement to get you to join is hereby
oted.
The authors are to be congratulated on an excellent presentation
n a topic that is becoming increasingly important in the field of
ealth care, and especially surgery. The push for quality improve-
ent and the means to measure what good quality is has already
ecome an important part of our daily practice and can only be
xpected to increase in importance in the future. Analyses such as
hese using data with risk adjustment are very important so that we
an accurately assess the progress we are making in improving the
uality of care we deliver to our patients. This analysis of more
han 700 patients who underwent operations in two separate Eu-
opean hospitals is a good example of how we, the surgeons,
hould lead the effort so that it can be done in a scientific manner
hat is valid and meaningful.
I have several questions for the author. In your report you used
model to predict the number of complications. Because there is
bviously a difference between someone with symptomatic post-
perative atrial fibrillation that is easily controlled with medication
ersus someone with adult respiratory distress syndrome that re-
uires prolonged ventilatory support and intensive care unit care,
ere you able to dissect out from your data the risk factors for
pecific complications, or was there insignificant statistical power
o provide for these types of specific predictions?
ic and Cardiovascular Surgery ● Volume 133, Number 1 95
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G
TSSecond, the question that always arises in the United States is
hether a board-certified thoracic surgeon has a better outcome
han a nonthoracic board-certified surgeon when performing a
ulmonary resection. Do you have the ability in your dataset to
nswer this question using these European data? Were all of these
rocedures performed by certified thoracic surgeons?
Finally, your statistical analysis is quite complicated, and I am
ertainly not a statistical expert; however, I am concerned about
he relatively small sample size you have. With only 743 patients
nd 35 deaths in your analysis, that leaves the standard error for
ge at plus or minus about 30% of the risk coefficient for age and
lus or minus 25% of the coefficient for the percent predicted
ostoperative FEV1. Did your statistician give you an estimate of
ow many additional patients you would need to obtain a lower
tandard of error, say, a plus or minus 5%. In other words, how
arge of a database do we need to accumulate to get a more specific
redictive number?
Again, I appreciate your efforts to provide us with stratification
n the field of pulmonary surgery and appreciate the opportunity to
iscuss this article. Thank you.
Dr Brunelli. Thank you, Dr Allen, for your kind comments and
our questions.
As to the first question, the complications, we did not weight
he complications, and therefore each complication was accounted
or similarly, and I think we did not have the numbers to individ-
ally dissect the complications, for example, to make separate
odels for pulmonary and cardiac complications. Therefore, the
umbers and the statistical power precluded us from making this
ubgroup analysis.
You asked about the qualifications of the surgeons. These two
enters were dedicated thoracic surgery units, and all of the sur-
eons were qualified, certified thoracic surgeons. Therefore we
ould not assess the differences between credentials of surgeons in
elation to outcome.
Finally, sample size is a major concern in our specialty when
ealing with audit analysis. These are the numbers. Of course, 35
eaths seems to be a low number, but we are confident that the
esults are reliable. We used bootstrap analysis to validate the
odel. The mortality model had two predictors, and therefore it is
ot overfitted, and the predictors had high stability with bootstrap
nalysis, which means that we repeated the regression analysis in
000 new simulated samples drawn with replacement from the
riginal dataset, and these variables turned out to be significant in
ore than 85% or 90% of cases. It took us 5 years to aggregate
hese data, and these two units have the average volume load in
urope, and this is a major concern. Even if you aggregate mul-iple units, let us say 10, 20, or 100 units, when dealing with audit t
6 The Journal of Thoracic and Cardiovascular Surgery ● Januand comparison between the units, we have to then apply the
odels to the single units or to the single surgeon and then you can
ave problems. Perhaps we have to shift from outcome measures
o other measures of quality of care, perhaps process measures,
hich are less affected by random noise and numbers and perhaps
ore linked to the quality. Therefore, the main purpose of this
tudy was to provide an example or method, and of course there
re limitations, but I think the limitations are inherent to the
utcome measures selected. For this first audit, we wanted to do a
omparative audit between two thoracic surgery units using the
wo most commonly used outcome measures, which are morbidity
nd mortality. But of course sample size is very important, and
erhaps we can change our mentality and shift from outcome
easures to process measures.
Dr Stephen C. Yang (Baltimore, Md). I am less of a statisti-
ian than Dr Allen, but how would you see the results to be
ifferent if there was a significant difference in mortality rates or
omplications between the two institutions? Would this model still
old?
Dr Brunelli. There was no significant difference—
Dr Yang. I know, but what if?
Dr Brunelli. Oh, what if? You have to assess whether there is
difference in the predicted and observed mortality within the
nits. Therefore let us say we have a big difference in mortality
ate, observed mortality rate between the two units. If the units
ere not in line with the predicted values, you can be confident
hat the difference is not due to poor performance but perhaps a
ifferent case mix.
Dr Joshua R. Sonett (New York, NY). But dead is dead in the
nd, and it does not matter what your risk model is if you have very
ad outcomes. If it is much higher, then maybe that is a reflection
f patient selection, which must be considered when evaluating
rograms and surgeons.
Dr Brunelli. Yes, but we are dealing with audit analysis and
erformance evaluation. Therefore it is unfair to judge a unit on
rude mortality rate without taking into account the case mix and
he prevalence of risk factors.
Dr Yang. Well, even if the case mixes are different, what about
he experience of the surgeons? Are they fairly well balanced
etween the 2 units?
Dr Brunelli. Yes. We explored this, and the structural and
rganizational characteristics of the two units were remarkably
imilar in credentials, experience of the surgeons, nurse-to-patient
atio, intensive care unit policy, and management. They both were
edicated thoracic surgery wards. We were confident that the
ualifications and experience of the surgeons and the structure of
he units were similar.
ry 2007
